Form D · Other Health Care

Venclose, Inc.

San Jose, CA · CIK 0001782738

Offering snapshot reported Nov 29, 2019 · SEC filing

Reported sold
$27.1M
Offering amount: $27.1M
Investors reported
67
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 3, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$13.5M$27.1MJul 17, 2019: $2,610,215.00Jul 17, 2019Nov 29, 2019: $27,096,736.00Nov 29, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,610,215 → $27,096,736
  • Reported investors41 → 67

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 29, 2019Amendment$27,096,736$24,486,521vs Jul 17, 201967SEC filing
Jul 17, 2019Initial$2,610,215No comparison41SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-344506

Source: Form D, filed Nov 29, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles Chon Director
Jerry Gibson Director, Executive
Peter Osborne Director, Executive
Jason Turner Executive
Greg Vislocky Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2570 N. First Street 2 Nd Floor #221
San Jose, CA, 95131